Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,628
archived clinical trials in
Schizophrenia

Neurocognitive Effects of Ziprasidone: Relationship to Working Memory and Dopamine Blockade
Neurocognitive Effects of Ziprasidone: Relationship to Working Memory and Dopamine Blockade
Status: Enrolling
Updated:  9/2/2015
The Zucker Hillside Hospital
mi
from
Glen Oaks, NY
Neurocognitive Effects of Ziprasidone: Relationship to Working Memory and Dopamine Blockade
Neurocognitive Effects of Ziprasidone: Relationship to Working Memory and Dopamine Blockade
Status: Enrolling
Updated: 9/2/2015
The Zucker Hillside Hospital
mi
from
Glen Oaks, NY
Click here to add this to my saved trials
An Open-Label Trial of Tocilizumab in Schizophrenia
An Open-Label Trial of Tocilizumab in Schizophrenia
Status: Enrolling
Updated:  9/3/2015
Georgia Health Sciences University
mi
from
Augusta, GA
An Open-Label Trial of Tocilizumab in Schizophrenia
An Open-Label Trial of Tocilizumab in Schizophrenia
Status: Enrolling
Updated: 9/3/2015
Georgia Health Sciences University
mi
from
Augusta, GA
Click here to add this to my saved trials
Electroconvulsive Therapy in Clozapine Refractory Schizophrenia
ECT in Clozapine Refractory Schizophrenia
Status: Enrolling
Updated:  9/15/2015
The Zucker Hillside Hospital
mi
from
Glen Oaks, NY
Electroconvulsive Therapy in Clozapine Refractory Schizophrenia
ECT in Clozapine Refractory Schizophrenia
Status: Enrolling
Updated: 9/15/2015
The Zucker Hillside Hospital
mi
from
Glen Oaks, NY
Click here to add this to my saved trials
Safety and PK Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Stable Schizophrenia
An Open-Label, Multiple Dose, Safety and Pharmacokinetic Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Patients With Chronic, Stable Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated:  9/16/2015
Collaborative Neuroscience Network, Inc.
mi
from
Long Beach, CA
Safety and PK Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Stable Schizophrenia
An Open-Label, Multiple Dose, Safety and Pharmacokinetic Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Patients With Chronic, Stable Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 9/16/2015
Collaborative Neuroscience Network, Inc.
mi
from
Long Beach, CA
Click here to add this to my saved trials
Acute Glycine Pharmacodynamic Study
Acute Glycine Pharmacodynamic Study
Status: Enrolling
Updated:  9/25/2015
McLean Imaging Center, McLean Hospital
mi
from
Belmont, MA
Acute Glycine Pharmacodynamic Study
Acute Glycine Pharmacodynamic Study
Status: Enrolling
Updated: 9/25/2015
McLean Imaging Center, McLean Hospital
mi
from
Belmont, MA
Click here to add this to my saved trials
Acute Effects of Exercise in Smokers With Schizophrenia
Acute Effects of Exercise in Smokers With Schizophrenia
Status: Enrolling
Updated:  9/25/2015
Brown University
mi
from
Providence, RI
Acute Effects of Exercise in Smokers With Schizophrenia
Acute Effects of Exercise in Smokers With Schizophrenia
Status: Enrolling
Updated: 9/25/2015
Brown University
mi
from
Providence, RI
Click here to add this to my saved trials
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated:  9/26/2015
Childrens National Medical Center
mi
from
Washington,
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated: 9/26/2015
Childrens National Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated:  9/26/2015
Henry Ford Health Systems
mi
from
Detroit, MI
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated: 9/26/2015
Henry Ford Health Systems
mi
from
Detroit, MI
Click here to add this to my saved trials
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated:  9/26/2015
Mt. Sinai Medical Center
mi
from
New York, NY
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated: 9/26/2015
Mt. Sinai Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated:  9/26/2015
Columbia University
mi
from
New York, NY
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated: 9/26/2015
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated:  9/26/2015
Genethon
mi
from
Every Cedex,
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Neuropsychological Evaluation of Psychiatric and Neurological Patients
Status: Enrolling
Updated: 9/26/2015
Genethon
mi
from
Every Cedex,
Click here to add this to my saved trials
A Study Evaluating the of OPC-34712 in Subjects With Normal Hepatic Function and Hepatically Impaired Subjects
A Single-dose, Open-label, Parallel Group, Matched Study Evaluating the Pharmacokinetics of Oral OPC-34712 Tablet in Subjects With Normal Hepatic Function and Hepatically Impaired Subjects
Status: Enrolling
Updated:  9/29/2015
Clinical Research Facility
mi
from
Miami, FL
A Study Evaluating the of OPC-34712 in Subjects With Normal Hepatic Function and Hepatically Impaired Subjects
A Single-dose, Open-label, Parallel Group, Matched Study Evaluating the Pharmacokinetics of Oral OPC-34712 Tablet in Subjects With Normal Hepatic Function and Hepatically Impaired Subjects
Status: Enrolling
Updated: 9/29/2015
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
A Study Evaluating the of OPC-34712 in Subjects With Normal Hepatic Function and Hepatically Impaired Subjects
A Single-dose, Open-label, Parallel Group, Matched Study Evaluating the Pharmacokinetics of Oral OPC-34712 Tablet in Subjects With Normal Hepatic Function and Hepatically Impaired Subjects
Status: Enrolling
Updated:  9/29/2015
Clinical Research Facility
mi
from
Minneapolis, MN
A Study Evaluating the of OPC-34712 in Subjects With Normal Hepatic Function and Hepatically Impaired Subjects
A Single-dose, Open-label, Parallel Group, Matched Study Evaluating the Pharmacokinetics of Oral OPC-34712 Tablet in Subjects With Normal Hepatic Function and Hepatically Impaired Subjects
Status: Enrolling
Updated: 9/29/2015
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Study Evaluating the of OPC-34712 in Subjects With Normal Hepatic Function and Hepatically Impaired Subjects
A Single-dose, Open-label, Parallel Group, Matched Study Evaluating the Pharmacokinetics of Oral OPC-34712 Tablet in Subjects With Normal Hepatic Function and Hepatically Impaired Subjects
Status: Enrolling
Updated:  9/29/2015
Clinical Research Facility
mi
from
San Antonio, TX
A Study Evaluating the of OPC-34712 in Subjects With Normal Hepatic Function and Hepatically Impaired Subjects
A Single-dose, Open-label, Parallel Group, Matched Study Evaluating the Pharmacokinetics of Oral OPC-34712 Tablet in Subjects With Normal Hepatic Function and Hepatically Impaired Subjects
Status: Enrolling
Updated: 9/29/2015
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Trial Evaluating OPC-34712 in Subjects With Normal Renal Function and Renally Impaired Subjects
A Single-dose, Open-label, Parallel-group, Matched Trial Evaluating the Pharmacokinetics of Oral OPC-34712 Tablets in Subjects With Normal Renal Function and Renally Impaired Subjects
Status: Enrolling
Updated:  9/29/2015
Otsuka Investigational Site
mi
from
Miami, FL
Trial Evaluating OPC-34712 in Subjects With Normal Renal Function and Renally Impaired Subjects
A Single-dose, Open-label, Parallel-group, Matched Trial Evaluating the Pharmacokinetics of Oral OPC-34712 Tablets in Subjects With Normal Renal Function and Renally Impaired Subjects
Status: Enrolling
Updated: 9/29/2015
Otsuka Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
Trial Evaluating OPC-34712 in Subjects With Normal Renal Function and Renally Impaired Subjects
A Single-dose, Open-label, Parallel-group, Matched Trial Evaluating the Pharmacokinetics of Oral OPC-34712 Tablets in Subjects With Normal Renal Function and Renally Impaired Subjects
Status: Enrolling
Updated:  9/29/2015
Otsuka Investigational Site
mi
from
Minneapolis, MN
Trial Evaluating OPC-34712 in Subjects With Normal Renal Function and Renally Impaired Subjects
A Single-dose, Open-label, Parallel-group, Matched Trial Evaluating the Pharmacokinetics of Oral OPC-34712 Tablets in Subjects With Normal Renal Function and Renally Impaired Subjects
Status: Enrolling
Updated: 9/29/2015
Otsuka Investigational Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Clinical Research Facility
mi
from
Charleston, SC
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Clinical Research Facility
mi
from
Little Rock, AR
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Clinical Research Facility
mi
from
Garden Grove, CA
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Clinical Research Facility
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Clinical Research Facility
mi
from
Glendale, CA
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Clinical Research Facility
mi
from
Glendale, CA
Click here to add this to my saved trials
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Clinical Research Facility
mi
from
Oakland, CA
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Clinical Research Facility
mi
from
Oakland, CA
Click here to add this to my saved trials
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Clinical Research Facility
mi
from
Oceanside, CA
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Clinical Research Facility
mi
from
Oceanside, CA
Click here to add this to my saved trials
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Clinical Research Facility
mi
from
San Diego, CA
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Clinical Research Facility
mi
from
Bradenton, FL
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Clinical Research Facility
mi
from
Bradenton, FL
Click here to add this to my saved trials
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Clinical Research Facility
mi
from
Miami Springs, FL
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Clinical Research Facility
mi
from
Miami Springs, FL
Click here to add this to my saved trials
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Clinical Research Facility
mi
from
Orlando, FL
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Clinical Research Facility
mi
from
Fresh Meadows, NY
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Clinical Research Facility
mi
from
Fresh Meadows, NY
Click here to add this to my saved trials
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Clinical Research Facility
mi
from
Jamaica, NY
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Clinical Research Facility
mi
from
Jamaica, NY
Click here to add this to my saved trials
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Clinical Research Facility
mi
from
Dayton, OH
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Clinical Research Facility
mi
from
Dayton, OH
Click here to add this to my saved trials
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Clinical Research Facility
mi
from
Austin, TX
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Clinical Research Facility
mi
from
Kirkland, WA
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Clinical Research Facility
mi
from
Kirkland, WA
Click here to add this to my saved trials
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated:  9/29/2015
mi
from
Burlington,
Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial of Three Fixed Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia
Status: Enrolling
Updated: 9/29/2015
mi
from
Burlington,
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
A Phase 2, 6-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 Once Daily and Aripiprazole Once Daily for Treatment of Hospitalized Adult Patients With Acute Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Clinical Research Facility
mi
from
Little Rock, AR
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
A Phase 2, 6-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 Once Daily and Aripiprazole Once Daily for Treatment of Hospitalized Adult Patients With Acute Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
A Phase 2, 6-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 Once Daily and Aripiprazole Once Daily for Treatment of Hospitalized Adult Patients With Acute Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Clinical Research Facility
mi
from
Escondido, CA
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
A Phase 2, 6-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 Once Daily and Aripiprazole Once Daily for Treatment of Hospitalized Adult Patients With Acute Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Clinical Research Facility
mi
from
Escondido, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
A Phase 2, 6-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 Once Daily and Aripiprazole Once Daily for Treatment of Hospitalized Adult Patients With Acute Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Clinical Research Facility
mi
from
Garden Grove, CA
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
A Phase 2, 6-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 Once Daily and Aripiprazole Once Daily for Treatment of Hospitalized Adult Patients With Acute Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Clinical Research Facility
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
A Phase 2, 6-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 Once Daily and Aripiprazole Once Daily for Treatment of Hospitalized Adult Patients With Acute Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Clinical Research Facility
mi
from
Long Beach, CA
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
A Phase 2, 6-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 Once Daily and Aripiprazole Once Daily for Treatment of Hospitalized Adult Patients With Acute Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
A Phase 2, 6-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 Once Daily and Aripiprazole Once Daily for Treatment of Hospitalized Adult Patients With Acute Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Clinical Research Facility
mi
from
Oceanside, CA
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
A Phase 2, 6-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 Once Daily and Aripiprazole Once Daily for Treatment of Hospitalized Adult Patients With Acute Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Clinical Research Facility
mi
from
Oceanside, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
A Phase 2, 6-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 Once Daily and Aripiprazole Once Daily for Treatment of Hospitalized Adult Patients With Acute Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Clinical Research Facility
mi
from
Pasadena, CA
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
A Phase 2, 6-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 Once Daily and Aripiprazole Once Daily for Treatment of Hospitalized Adult Patients With Acute Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Clinical Research Facility
mi
from
Pasadena, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
A Phase 2, 6-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 Once Daily and Aripiprazole Once Daily for Treatment of Hospitalized Adult Patients With Acute Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Clinical Research Facility
mi
from
San Diego, CA
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
A Phase 2, 6-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 Once Daily and Aripiprazole Once Daily for Treatment of Hospitalized Adult Patients With Acute Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
A Phase 2, 6-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 Once Daily and Aripiprazole Once Daily for Treatment of Hospitalized Adult Patients With Acute Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Clinical Research Facility
mi
from
Santa Ana, CA
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
A Phase 2, 6-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 Once Daily and Aripiprazole Once Daily for Treatment of Hospitalized Adult Patients With Acute Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Clinical Research Facility
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
A Phase 2, 6-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 Once Daily and Aripiprazole Once Daily for Treatment of Hospitalized Adult Patients With Acute Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Clinical Research Facility
mi
from
Washington,
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
A Phase 2, 6-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 Once Daily and Aripiprazole Once Daily for Treatment of Hospitalized Adult Patients With Acute Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
A Phase 2, 6-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 Once Daily and Aripiprazole Once Daily for Treatment of Hospitalized Adult Patients With Acute Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Clinical Research Facility
mi
from
Bradenton, FL
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
A Phase 2, 6-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 Once Daily and Aripiprazole Once Daily for Treatment of Hospitalized Adult Patients With Acute Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Clinical Research Facility
mi
from
Bradenton, FL
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
A Phase 2, 6-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 Once Daily and Aripiprazole Once Daily for Treatment of Hospitalized Adult Patients With Acute Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Clinical Research Facility
mi
from
Maitland, FL
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
A Phase 2, 6-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 Once Daily and Aripiprazole Once Daily for Treatment of Hospitalized Adult Patients With Acute Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Clinical Research Facility
mi
from
Maitland, FL
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
A Phase 2, 6-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 Once Daily and Aripiprazole Once Daily for Treatment of Hospitalized Adult Patients With Acute Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Clinical Research Facility
mi
from
St. Louis, MO
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
A Phase 2, 6-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 Once Daily and Aripiprazole Once Daily for Treatment of Hospitalized Adult Patients With Acute Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Clinical Research Facility
mi
from
St. Louis, MO
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
A Phase 2, 6-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 Once Daily and Aripiprazole Once Daily for Treatment of Hospitalized Adult Patients With Acute Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Clinical Research Facility
mi
from
Cedarhurst, NY
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
A Phase 2, 6-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 Once Daily and Aripiprazole Once Daily for Treatment of Hospitalized Adult Patients With Acute Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Clinical Research Facility
mi
from
Cedarhurst, NY
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
A Phase 2, 6-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 Once Daily and Aripiprazole Once Daily for Treatment of Hospitalized Adult Patients With Acute Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
A Phase 2, 6-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 Once Daily and Aripiprazole Once Daily for Treatment of Hospitalized Adult Patients With Acute Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
A Phase 2, 6-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 Once Daily and Aripiprazole Once Daily for Treatment of Hospitalized Adult Patients With Acute Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Clinical Research Facility
mi
from
Austin, TX
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
A Phase 2, 6-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 Once Daily and Aripiprazole Once Daily for Treatment of Hospitalized Adult Patients With Acute Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
A Phase 2, 6-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 Once Daily and Aripiprazole Once Daily for Treatment of Hospitalized Adult Patients With Acute Schizophrenia
Status: Enrolling
Updated:  9/29/2015
Study Site
mi
from
Burgas,
Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 and Aripiprazole for Treatment of Acute Schizophrenia
A Phase 2, 6-Week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Oral OPC-34712 Once Daily and Aripiprazole Once Daily for Treatment of Hospitalized Adult Patients With Acute Schizophrenia
Status: Enrolling
Updated: 9/29/2015
Study Site
mi
from
Burgas,
Click here to add this to my saved trials
Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
A Parallel-arm, Double-blind, Placebo and Positive Controlled Multiple Oral Dose Administration Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated:  9/29/2015
Otsuka Investigational Site
mi
from
Long Beach, CA
Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
A Parallel-arm, Double-blind, Placebo and Positive Controlled Multiple Oral Dose Administration Trial to Evaluate the Effects of OPC-34712 on QT/QTc in Subjects With Schizophrenia or Schizoaffective Disorder
Status: Enrolling
Updated: 9/29/2015
Otsuka Investigational Site
mi
from
Long Beach, CA
Click here to add this to my saved trials